Health Venture Lab Alumni

What we love about the programme is the training first, it almost feels like we had a hands-on MBA completed during these four months.

Our goal for Reactor was to understand how we can help medical device teams with accelerating the product design. Through the programme, we had the opportunity to speak with experts in the field, understand the challenges those teams face in their daily activities and identify exactly how we can make their lives better so medical devices can end up faster in the hands of those who need it most.

Joining the Reactor as the already ongoing company helped us confirm our strategy, identify the next steps, and contact top experts. We got insights into putting our strategy to action with realistic tips regarding many topics, such as commercial pitches, communication processes, how to expand our market, and many other crucial topics that were essential at that time for us.  Whether you are a newly born company or a company with a few years of experience - you will do things better after this unique business experience.

The Reactor programme was a huge opportunity for our company because we could validate product marketability with participating SMEs, experts, and selected mentors. We have received significant assistance in assessing our market situation and preparing key strategic and financial documentation. We were able to identify the most important market segments and prepare a market entry schedule. The online Sprints were well-organized, HVL and GE Healthcare staff managed the programme professionally.

Participating at the Reactor allowed us to take a bigger perspective on the MedTech market as we were meeting teams from different countries and examining different strategies. By having access to all expertise we could imagine, backed by GE Healthcare, we absorbed all essential business knowledge (sales, marketing, public speaking) to convert our solution into a fully-fledged business.

I certainly recommend this programme, as it helps you to learn how to do business very well. Most of the teams have their technical side assured, but you also have to know how to do business, and the HVL programme supports you precisely with that.

The Reactor programme gave us real benefits. We have received deep knowledge of the European healthcare sector, marketing and sales of medical devices. Such relevant lectures and 1:1 discussions with experts have widened our understanding of how we should act on the market and the specificities we should consider. A big plus of the programme was that it gave us an opportunity to meet with GE Healthcare experts who work in the same field but also have decades of international experience in various healthcare aspects (sales, software engineering, product development, legal issues, etc.). 

HVL's Reactor accelerator was a great opportunity to meet relevant people within GE Healthcare. It helped Lightspace build a new network with professionals and get their direct feedback. Another point worth mentioning is the trainer and one of the leading advisers who definitely gave the right boost for entrepreneurs in getting ready to do the really impactful pitch.

The Reactor was the best start into the GE Healthcare ecosystem we can think of: they always had our progress in mind, connected us to the right people at GE and as a cherry on top, we've got valuable feedback from inspiring minds. Despite it being fully digital, the HVL team managed to create a sense of community among the team and the startups. It's no wonder therefore we love moving forward with GE Healthcare and are now part of the Edison Developer Event and had a first joint customer visit at a GE KOL.

Being part of Reactor’21 helped our company in many ways. It allowed us to challenge our value proposition with subject matter experts, potential end-users, and partners, supporting us in shifting towards a different positioning. This allowed closing a number of partnerships with distributors and being selected for GE Healthcare's Edison Developer Event, an impressive journey that culminated in a demo to their clinical leadership team.